Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin R Lynch

Showing results (51-60 of 100) with videos related to

Pageof 10
Sort By:
Neuropharmacology|October 22, 2011
Distinct generation, pharmacology, and distribution of sphingosine 1-phosphate and dihydrosphingosine 1-phosphate in human neural progenitor cellsPhillip Callihan, Nicholas C Zitomer, Michael V Stoeling, et al.
Clinical Immunology (Orlando, Fla.)|May 10, 2003
The immune modulator FYT720 prevents autoimmune diabetes in nonobese diabetic miceZandong Yang, Meng Chen, Lawrence B Fialkow, et al.
Bioorganic & Medicinal Chemistry|November 23, 2006
Synthesis and biological evaluation of gamma-aminophosphonates as potent, subtype-selective sphingosine 1-phosphate receptor agonists and antagonistsFrank W Foss, Ashley H Snyder, Michael D Davis, et al.
Journal of Medicinal Chemistry|November 13, 2007
Asymmetric synthesis of conformationally constrained fingolimod analogues--discovery of an orally active sphingosine 1-phosphate receptor type-1 agonist and receptor type-3 antagonistRan Zhu, Ashley H Snyder, Yugesh Kharel, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 6, 2015
Sphingosine Kinase 2 Inhibition and Blood Sphingosine 1-Phosphate LevelsYugesh Kharel, Emily A Morris, Molly D Congdon, et al.
Theranostics|January 8, 2019
Photoacoustic microscopy reveals the hemodynamic basis of sphingosine 1-phosphate-induced neuroprotection against ischemic strokeRui Cao, Jun Li, Yugesh Kharel, et al.
Blood|July 31, 2014
Acid sphingomyelinase is activated in sickle cell erythrocytes and contributes to inflammatory microparticle generation in SCDAnthony O Awojoodu, Philip M Keegan, Alicia R Lane, et al.
The Biochemical Journal|February 14, 2009
Lipid phosphate phosphohydrolase type 1 (LPP1) degrades extracellular lysophosphatidic acid in vivoJose L Tomsig, Ashley H Snyder, Evgeny V Berdyshev, et al.
American Journal of Physiology. Renal Physiology|January 13, 2006
Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidneyAlaa S Awad, Hong Ye, Liping Huang, et al.
European Journal of Medicinal Chemistry|January 14, 2021
Probing the substitution pattern of indole-based scaffold reveals potent and selective sphingosine kinase 2 inhibitorsMolly Congdon, Russell G Fritzemeier, Yugesh Kharel, et al.
Pageof 10

Showing results (51-60 of 100) with videos related to

Sort By:
Pageof 10
Neuropharmacology|October 22, 2011
Distinct generation, pharmacology, and distribution of sphingosine 1-phosphate and dihydrosphingosine 1-phosphate in human neural progenitor cellsPhillip Callihan, Nicholas C Zitomer, Michael V Stoeling, et al.
Clinical Immunology (Orlando, Fla.)|May 10, 2003
The immune modulator FYT720 prevents autoimmune diabetes in nonobese diabetic miceZandong Yang, Meng Chen, Lawrence B Fialkow, et al.
Bioorganic & Medicinal Chemistry|November 23, 2006
Synthesis and biological evaluation of gamma-aminophosphonates as potent, subtype-selective sphingosine 1-phosphate receptor agonists and antagonistsFrank W Foss, Ashley H Snyder, Michael D Davis, et al.
Journal of Medicinal Chemistry|November 13, 2007
Asymmetric synthesis of conformationally constrained fingolimod analogues--discovery of an orally active sphingosine 1-phosphate receptor type-1 agonist and receptor type-3 antagonistRan Zhu, Ashley H Snyder, Yugesh Kharel, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 6, 2015
Sphingosine Kinase 2 Inhibition and Blood Sphingosine 1-Phosphate LevelsYugesh Kharel, Emily A Morris, Molly D Congdon, et al.
Theranostics|January 8, 2019
Photoacoustic microscopy reveals the hemodynamic basis of sphingosine 1-phosphate-induced neuroprotection against ischemic strokeRui Cao, Jun Li, Yugesh Kharel, et al.
Blood|July 31, 2014
Acid sphingomyelinase is activated in sickle cell erythrocytes and contributes to inflammatory microparticle generation in SCDAnthony O Awojoodu, Philip M Keegan, Alicia R Lane, et al.
The Biochemical Journal|February 14, 2009
Lipid phosphate phosphohydrolase type 1 (LPP1) degrades extracellular lysophosphatidic acid in vivoJose L Tomsig, Ashley H Snyder, Evgeny V Berdyshev, et al.
American Journal of Physiology. Renal Physiology|January 13, 2006
Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidneyAlaa S Awad, Hong Ye, Liping Huang, et al.
European Journal of Medicinal Chemistry|January 14, 2021
Probing the substitution pattern of indole-based scaffold reveals potent and selective sphingosine kinase 2 inhibitorsMolly Congdon, Russell G Fritzemeier, Yugesh Kharel, et al.
Pageof 10